Filing Flows › Apyx Medical (APYX) › R&D spending
Apyx Medical (APYX) R&D spending by quarter
Apyx Medical's R&D spending was $849K in Q3 2026 (third quarter 2026), +7% from Q2 2026. Over the last 7 quarters it ranged from $765K (Q1 2026) to $944K (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $849K | +7% | +6% |
| Q2 2026 | $793K | +4% | -4% |
| Q1 2026 | $765K | -19% | -5% |
| Q4 2025 | $944K | +18% | — |
| Q3 2025 | $801K | -3% | — |
| Q2 2025 | $824K | +2% | — |
| Q1 2025 | $804K | — | — |
Q3 2026 at a glance
Apyx Medical, Q3 2026: revenue $14.0M (+9% year over year), operating margin -4.1%, net loss $1.8M, operating cash flow −$1.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is Apyx Medical's R&D spending?
Apyx Medical's R&D spending was $849K in Q3 2026 (third quarter 2026), +7% from Q2 2026.
How has Apyx Medical's R&D spending changed?
Over the last 7 quarters it ranged from $765K (Q1 2026) to $944K (Q4 2025).